Business Wire | Sep 1, 2020 08:00AM EDT

Horizon Therapeutics plc to Present at the Morgan Stanley 18th Annual Global Healthcare Conference

Sep. 01, 2020

DUBLIN--(BUSINESS WIRE)--Sep. 01, 2020--Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company will participate in the following conference in September:

Morgan Stanley 18th Annual Global Healthcare Conference (Virtual)

* Date: Wednesday, Sept. 16, 2020 * Presentation Time: 12:30 p.m. ET

The conference presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizontherapeutics.com. A replay of the webcast will be available for the event.

About Horizon

Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, please visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200901005174/en/

CONTACT: Investors: Tina Ventura Senior Vice President, Investor Relations investor-relations@horizontherapeutics.com

CONTACT: Ruth Venning Executive Director, Investor Relations investor-relations@horizontherapeutics.com

CONTACT: U.S. Media: Geoff Curtis Executive Vice President, Corporate Affairs & Chief Communications Officer media@horizontherapeutics.com

CONTACT: Ireland Media: Ray Gordon Gordon MRM ray@gordonmrm.ie